FULL PAPERS
Dynamic Reductive Kinetic Resolution of Benzyl Ketones
3
(CH, syn+anti), 115.9 (2CH, syn+anti), 129.5 (2CH, syn+
anti), 135.6 (C, syn+anti), 155.0 (C, syn+anti); HR-MS
(ESI+): m/z=189.08920, calcd. for (C10H14NaO2)+ (M+
Na)+: 189.08915.
syn+anti), 129.1 (d, JC,F =4.9 Hz, CH, syn+anti), 130.3 (C,
1
syn+anti), 161.1 (d, JC,F =244.6 Hz, C, syn+anti); HR-MS
(ESI+): m/z=191.19786, calcd. for (C10H13FNaO)+ (M+
Na)+: 191.19779.
3-(4’-Nitrophenyl)butan-2-ol (3d): Colourless oil; yield:
96%; Rf (50% Et2O/hexane): 0.53; diastereomeric ratio for
(Æ)-3d (syn:anti)=23:77; IR (NaCl): n=3360, 3055, 2969,
3-Phenylpentan-2-ol (3h): Colourless oil; yield: 97%; Rf
(50% Et2O/hexane): 0.57; diastereomeric ratio for (Æ)-3h
(syn:anti)=19:81; IR (NaCl): n=3227, 1493, 1050, 740,
1
1
3
1473, 1374, 1222, 860 cmÀ1; H NMR (300.13 MHz, CDCl3):
703 cmÀ1; H NMR (300.13 MHz, CDCl3): d=0.78 (t, JH,H
=
3
3
d=1.11 (d, JH,H =6.3 Hz, 3H, syn), 1.23 (d, JH,H =6.2 Hz,
7.4 Hz, 3H, syn+anti), 1.23 (d, 3JH,H =6.2 Hz, 3H, syn+
anti), 1.37 (br s, 1H, syn+anti), 1.61–1.71 (m, 1H, syn+
anti), 1.76–1.86 (m, 1H, syn+anti), 2.39–2.47 (m, 1H, syn+
anti), 3.90–3.99 (m, 1H, syn+anti), 7.22–7.29 (m, 3H, syn+
anti), 7.33–7.38 (m, 2H, syn+anti); 13C NMR (75.5 MHz,
CDCl3): d=12.6 (CH3, syn+anti), 21.5 (CH3, syn+anti),
25.2 (CH2, syn+anti), 56.4 (CH, syn+anti), 71.5 (CH, syn+
anti), 127.1 (CH, syn+anti), 128.9 (CH, syn+anti), 129.3
(CH, syn+anti), 141.7 (C, syn+anti); HR-MS (ESI+): m/z=
187.10993, calcd. for (C11H16NaO)+ (M+Na)+: 187.10988.
3-Phenylhexan-2-ol (3i): Yellow oil; yield: 98%; Rf (50%
Et2O/hexane): 0.60; diastereomeric ratio for (Æ)-3i (syn:an-
ti)=15:85; IR (NaCl): n=3350, 2957, 1487, 1051, 748,
3
3
3H, anti), 1.33 (d, JH,H =7.1 Hz, 3H, anti), 1.37 (d, JH,H
=
7.0 Hz, 3H, syn), 1.50 (br s, 1H, syn+anti), 2.80–2.92 (m,
1H, syn+anti), 3.93–3.99 (m, 1H, syn+anti), 7.38–7.45 (m,
2H, syn+anti), 8.16–8.20 (m, 2H, syn+anti); 13C NMR
(75.5 MHz, CDCl3): d=15.6 (CH3, syn), 17.7 (CH3, anti),
21.2 (CH3, anti), 21.3 (CH3, syn), 47.1 (CH, syn), 47.5 (CH,
anti), 71.8 (CH, syn), 71.9 (CH, anti), 123.6 (2CH, syn+
anti), 128.7 (2CH, syn), 129.0 (2CH, anti), 146.7 (C, syn+
anti), 151.8 (C, syn+anti); HR-MS (ESI+) m/z=218.07928,
calcd. for (C10H13NNaO3)+ (M+Na)+: 218.07931.
3-(2’-Methoxyphenyl)butan-2-ol (3e): Yellow oil (99%);
Rf (50% Et2O/hexane): 0.47; diastereomeric ratio for (Æ)-3e
(syn:anti): 13:87; IR (NaCl): n=3390, 3045, 2967, 1477,
1
3
703 cmÀ1; H NMR (300.13 MHz, CDCl3): d=0.85 (t, JH,H
=
1
1267, 742 cmÀ1; H NMR (300 MHz, CDCl3): d=1.12 (d, J=
7.3 Hz, 3H, syn+anti), 1.10–1.20 (m, 2H, syn+anti), 1.23 (d,
3JH,H =6.2 Hz, 3H, syn+anti), 1.37 (br s, 1H, syn+anti),
1.61–1.71 (m, 1H, syn+anti), 1.76–1.86 (m, 1H, syn+anti),
2.50–2.57 (m, 1H, syn+anti), 3.90–3.99 (m, 1H, syn+anti),
7.22–7.29 (m, 3H, syn+anti), 7.33–7.38 (m, 2H, syn+anti);
13C NMR (75.5 MHz, CDCl3): d=14.5 (CH3, syn+anti), 21.1
(CH2, syn+anti), 21.5 (CH3, syn+anti), 33.7 (CH2, syn), 34.5
(CH2, anti), 54.0 (CH, syn), 54.2 (CH, anti), 71.7 (CH, anti),
72.2 (CH, syn), 126.8 (CH, syn), 127.1 (CH, anti), 128.7
(CH, syn), 128.9 (CH, anti), 129.2 (CH, syn+anti), 142.0 (C,
syn+anti); HR-MS (ESI+): m/z=201.12556, calcd. for
(C12H18NaO)+ (M+Na)+: 201.12553.
3-Phenyl-hex-5-en-2-ol (3j): Yellow oil; yield: 98%; Rf
(50% Et2O/hexane): 0.48; IR (NaCl): n=3323, 2977, 1641,
1161, 760, 702 cmÀ1; diastereomeric ratio for (Æ)-3j (syn:an-
ti)=21:79; 1H NMR (300.13 MHz, CDCl3): d=1.07, (d,
3JH,H =6.3 Hz, 3H, syn), 1.21, (d, 3JH,H =6.3 Hz, 3H, anti)
1.53 (brs, 1H), 2.46–2.69 (m, 2H, syn+anti), 3.98–4.02 (m,
1H, syn+anti), 4.92–5.06 (m, 2H, syn+anti), 5.59–5.70 (m,
1H, syn+anti), 7.17–7.38 (m, 5H); 13C NMR (75.5 MHz,
CDCl3): d 21.5 (CH3, syn+anti), 35.9 (CH2, syn), 36.8 (CH2,
anti), 53.8 (CH, anti), 53.9 (CH, syn), 70.4 (CH, anti), 70.5
(CH, syn), 116.3 (CH2,syn), 116.6 (CH2, anti), 127.0 (CH,
syn), 127.2 (CH, anti), 128.8 (CH, syn), 128.9 (CH, anti),
129.0 (CH, syn) 129.4 (CH, anti), 137.0 (CH, anti), 137.4
(CH, syn), 141.1 (C); HR-MS (ESI+): m/z=199.10991,
calcd. for (C12H16NaO)+ (M+Na)+: 199.10988.
6.3 Hz, 3H, syn), 1.22 (d, J=6.2 Hz, 3H, anti), 1.26 (d, J=
7.2 Hz, 3H, anti), 1.30 (d, J=7.2 Hz, 3H, syn), 1.86 (brs, 1H,
syn+anti), 3.21–3.33 (m, 1H, syn+anti), 3.85 (s, 3H, syn+
anti) 3.92–4.01 (m, 1H, syn+anti), 6.89–7.00 (m, 2H, syn+
anti), 7.19–7.26 (m, 2H, syn+anti); 13C NMR (75.5 MHz,
CDCl3): d=15.2 (CH3, syn), 17.1 (CH3, anti), 21.0 (CH3,
syn), 21.1 (CH3, anti), 39.8 (CH, syn), 40.8 (CH, anti), 55.8
(CH, anti+syn), 111.0 (CH, syn), 111.1 (CH, anti), 121.1
(CH, syn), 121.3 (CH, anti), 127.6 (CH, syn), 127.8 (CH,
anti), 128.6 (anti+syn), 132.1 (C, syn), 132.3 (C, anti), 157.4
(C, syn), 157.8 (C, anti); HR-MS (ESI+): m/z=203.10487,
calcd. for (C11H16NaO2)+ (M+Na)+: 203.10480.
3-(2’-Methylphenyl)butan-2-ol (3f): Colourless oil; yield:
90%; Rf (50% Et2O/hexane): 0.47; diastereomeric ratio for
(Æ)-3f (syn:anti)=13:87; IR (NaCl): n=3203, 2951, 1490,
1222, 1035, 742 cmÀ1
;
1H NMR (300.13 MHz, CDCl3): d=
3
3
1.14 (d, JH,H =6.3 Hz, 3H, syn), 1.22 (d, JH,H =7.0 Hz, 3H,
3
anti), 1.30 (d, JH,H =6.1 Hz, 3H, syn+anti), 1.69 (br s, 1H,
syn+anti), 2.36 (s, 3H, syn) 2.39 (s, 3H, anti), 2.91–3.24 (m,
1H, syn+anti), 3.92–3.96 (m, 1H, syn+anti), 7.13–7.30 (m,
4H, syn+anti); 13C NMR (75.5 MHz, CDCl3): d=18.3 (CH3,
syn+anti), 20.3 (CH3, syn+anti), 20.9 (CH3, syn+anti), 40.0
(CH, syn+anti), 72.7 (CH, syn+anti), 126.2 (CH, syn+anti),
126.6 (CH, syn+anti), 126.9 (CH, syn+anti), 137.2 (C, syn+
anti), 142.5 (C, syn+anti); HR-MS (ESI+): m/z=calcd. for
(C11H16NaO)+ (M+Na)+: 187.10988.
3-(2’-Fluorophenyl)butan-2-ol (3g): Colourless oil; yield:
97%; Rf (50% Et2O/hexane): 0.51; diastereomeric ratio for
(Æ)-3g (syn:anti)=16:84; IR (NaCl): n=3350, 2920, 1489,
3-Phenylheptan-2-ol (3k): Colourless oil; yield: 95%; Rf
(50% Et2O/hexane): 0.62; diastereomeric ratio for (Æ)-3k
(syn:anti)=14:86; IR (NaCl): n=3366, 2917, 1399, 1061,
1237, 752 cmÀ1
;
1H NMR (300.13 MHz, CDCl3): d=
743, 700 cmÀ1 1H NMR (300.13 MHz, CDCl3): d=0.85 (t,
;
1H NMR (300 MHz, CDCl3): d=1.14 (d, J=6.3 Hz, 3H,
syn), 1.23 (d, J=6.2 Hz, 3H, anti), 1.31 (d, J=7.2 Hz, 3H,
anti), 1.36 (d, J=7.1 Hz, 3H, syn), 1.55 (brs, 1H, syn+anti),
3.09–3.18 (m, 1H, syn+anti), 3.95–4.03 (m, 1H, syn+anti),
7.03–7.34 (m, 4H, syn+anti); 13C NMR (75.5 MHz, CDCl3):
d=15.1 (CH3, syn), 16.8 (CH3, anti), 20.8 (CH3, anti), 21.1
(CH3, syn) 40.0 (CH, syn), 40.3 (CH, anti), 71.3 (CH, anti),
3JH,H =7.2 Hz, 3H, syn+anti), 1.04–1.18 (m, 2H, syn+anti),
1.23 (d, 3JH,H =6.3 Hz, 3H, syn+anti), 1.26–1.34 (m, 2H,
syn+anti) 1.45 (br s, 1H, syn+anti), 1.64–1.76 (m, 2H,
syn+anti), 2.48–2.55 (m, 1H, syn+anti), 3.89–3.97 (m, 1H,
syn+anti), 7.22–7.29 (m, 3H, syn+anti), 7.33–7.41 (m, 2H,
syn+anti); 13C NMR (75.5 MHz, CDCl3): d=14.3 (CH3,
syn+anti), 21.5 (CH3, syn+anti), 23.1 (CH2, syn+anti), 30.1
(CH2, syn+anti), 32.0 (CH2, syn+anti), 54.5 (CH, syn+
anti), 71.7 (CH, syn+anti), 127.1 (CH, syn+anti), 128.7
2
71.4 (CH, syn) 115.5 (d, JC,F =23.2 Hz, CH, syn+anti), 124.2
4
3
(CH, d, JC,F =3.2 Hz syn+anti), 127.9 (d, JC,F =8.4 Hz, CH,
Adv. Synth. Catal. 2016, 358, 122 – 131
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
129